
United States · Biotechnology Research startup
Thrive Bioscience (www.thrivebio.com), based in the Greater Boston Area, develops and markets a suite of automated live cell imaging systems and advanced software tools that transf
Funding reportedLast round: Convertible note
Thrive Bioscience (www.thrivebio.com), based in the Greater Boston Area, develops and markets a suite of automated live cell imaging systems and advanced software tools that transf
orm how scientists capture, analyze, and utilize cell-based data. Thrive empowers researchers to generate richer, more reproducible results through high-resolution, label-free imaging and quantitative analytics. By integrating cutting-edge microscopy, robotics, and fluidics, Thrive’s instruments automate the imaging and data capture of live cells over time, building structured, searchable databases of deep biological information that enable better experimental design, more reliable insights, and accelerated discoveries. Thrive’s platforms also produce standardized, high-quality datasets ideal for AI and machine learning applications, helping to unlock new predictive capabilities and data-driven biological insights. Researchers across drug discovery, drug development, regenerative medicine, infectious disease, and basic research use Thrive’s solutions to reimagine workflows, improve reproducibility, and enhance the quality and impact of their science.
Funding, as reported
From the SEC filings it signed: 2 on the team.
On the board, as filediBrock Philippe ReeveGuy Philippe BroadbentMichael Philippe Finney
Add your raise, your deck and your story, and put Thrive Bioscience, Inc. in front of investors. Or tell us what we have wrong.